Discover
CRMD
CorMedix Inc.
7.72
2 x 5.35
2 x 9.71
bid
ask
-
0.07
0.90%
2 @ 07:30 PM
7.51 -0.21 (2.72%)
| Ytd | -33.62% | |
| 1y | -33.96% |
7.62
day range
7.79
6.25
52 week range
12.73
| Open | 7.62 | Prev Close | 7.79 | Low | 7.62 | High | 7.79 | Mkt Cap | 601.73M |
| Vol | 1.81M | Avg Vol | 1.21M | EPS | 2.18 | P/E | 3.54 | Forward P/E | 17.54 |
| Beta | 1.58 | Short Ratio | 5.12 | Inst. Own | 31.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 7.98 | 200-d Avg | 8.18 | 1yr Est | 16.25 |
| Income Statement | |||
| Total Revenue | 101.93M | ||
| Revenues (USD) | 101.93M | ||
| Cost of Revenue | 24.81M | ||
| Gross Profit | 77.13M | ||
| Operating Expenses | 34.22M | ||
| Research and Development Expense | 6.68M | ||
| Selling, General and Administrative Expense | 27.53M | ||
| Operating Income | 42.91M | ||
| Income Tax Expense | 12.75M | ||
| Net Income | 25.99M | ||
| Net Income Common Stock | 25.99M | ||
| Net Income Common Stock (USD) | 25.99M | ||
| Consolidated Income | 25.99M | ||
| Earnings per Basic Share | 0.33 | ||
| Earnings per Basic Share (USD) | 0.33 | ||
| Earnings per Diluted Share | 0.29 | ||
| Earning Before Interest & Taxes (EBIT) | 38.73M | ||
| Earning Before Interest & Taxes (USD) | 38.73M | ||
| Weighted Average Shares | 78.44M | ||
| Weighted Average Shares Diluted | 92.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 256.69M | ||
| Cash and Equivalents (USD) | 256.69M | ||
| Trade and Non-Trade Receivables | 161.31M | ||
| Current Assets | 480.55M | ||
| Property, Plant & Equipment Net | 7.85M | ||
| Total Assets | 904.05M | ||
| Total Debt | 145.15M | ||
| Current Liabilities | 187.40M | ||
| Debt Non-Current | 145.15M | ||
| Total Liabilities | 443.22M | ||
| Accumulated Retained Earnings (Deficit) | -111.99M | ||
| Accumulated Other Comprehensive Income | 2.00K | ||
| Shareholders Equity | 460.83M | ||
| Shareholders Equity (USD) | 460.83M | ||
| Assets Non-Current | 423.50M | ||
| Total Debt (USD) | 145.15M | ||
| Goodwill and Intangible Assets | 388.47M | ||
| Inventory | 38.58M | ||
| Liabilities Non-Current | 255.82M | ||
| Trade and Non-Trade Payables | 10.24M | ||
| Tax Liabilities | 663.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 10.54M | ||
| Net Cash Flow from Financing | -7.07M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 78.61M | ||
| Capital Expenditure | -561.00K | ||
| Issuance (Purchase) of Equity Shares | -6.16M | ||
| Net Cash Flow from Investing | -561.00K | ||
| Net Cash Flow from Operations | 86.24M | ||
| Share Based Compensation | 4.08M | ||